Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Second Quarter Reports Are Solid Last week saw the very...
The ChinaBio® Stock Index, comprised of 17...
China biopharma stocks listed on US exchanges weathered a...
The 4th ChinaBio® Investor Forum showed China...
As China biopharma continues to evolve, the once dominant...
China currently ranks number two in the world in the...
At the recent ChinaBio® Partnering Forum, three...
Merck plans to build an innovative drug R&D facility in...
A US judge ordered the Big Four accounting firms to...
China issued updated rules for stem cell clinical trials,...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
